This Million Shows Growing Confidence in 10x Genomics
A hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Biotech insights await. This page curates 5 articles on Tempus, Moderna, Praxis, ImmunityBio and market moves to help you evaluate stocks and sharpen your portfolio strategy.
134 articlesA hedge fund recently boosted its position in 10x Genomics, highlighting growing confidence in the biotech tools make...
Halozyme’s halo (HALO) 2026 earnings landscape hinges on ENHANZE collaborations, pipeline milestones, and disciplined...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
A limited hantavirus outbreak has sent waves through biotech stocks, mirroring post-pandemic behavior. This article b...
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Smart investors look beyond the loud headlines. This guide explains how overlooked stocks soar 2026 by spotting catal...
What could turn a biotech bet into a life-changing gain? This article breaks down how to spot this millionaire-maker ...
Vericel faces a pivotal 2026 earnings season. This guide breaks down the drivers behind the numbers, what to watch in...
Investors are watching Crinetics' Q1 2026 results for clues on milestones, cash runway, and partnerships. This guide ...
A clear guide to reading RMTI's Q1 2026 earnings call, what the numbers mean, and how to spot the catalysts that can ...
As Progyny gears up for 2026, investors want clarity on what drives progyny (pgny) 2026 earnings. This guide breaks d...
Amphastar delivered a careful Q1 2026 showing steady revenue momentum and margin discipline. This guide breaks down t...